Chinese Traditional and Herbal Drugs
|
2025, 56(16): 5981-5993
Research progress on effects and mechanisms of flavonoids in treatment of cholestatic liver injury
Full
LIU Mingrui, DONG Jiahao, YUAN Cheng, WU Hao, QIAN Binglu, GAO Zihan, LIU Yingjiao
Affiliations
About Author:
国家自然科学基金资助项目 (82360782); 江西省自然科学基金资助项目 (20232BAB206170); 江西省中医药管理局科技计划项目 (2021A333); 江西省卫生健康委科技计划项目 (202211412); 江西省“十四五”期间药学一流专业建设经费 (202410412036); 江西中医药大学国家级大学生创新创业训练计划 (202410412036)
doi: 10.7501/j.issn.0253-2670.2025.16.026
Outline
Cholestatic liver injury (CLI) results from disrupted bile metabolism and chronic exposure of the liver to toxic bile acids. Bile acid homeostasis imbalance, inflammatory responses, and oxidative stress are key factors in the development of CLI, which can progress to hepatic fibrosis, cirrhosis, liver neoplasms, and eventually liver failure if treatment is belated. Flavonoids exhibit diverse pharmacological activities, including anti-inflammatory, antioxidant, and anticancer effects, coupled with modulation of critical cellular enzymes. They effectively alleviate CLI by restoring bile acid homeostasis, inhibiting inflammatory responses, and reducing oxidative stress, with few adverse reactions. Therefore, flavonoids are expected to be a novel kind of medicine for cholestatic liver disease. This review discusses the therapeutic effects and pharmacological mechanisms of flavonoids, extracted from medicinal plants, on CLI in recent years. Additionally, it provides a reference for the clinical application and the new drug development of flavonoids in treatment of CLI.
cholestatic liver injury
/
flavonoids
/
bile acid homeostasis imbalance
/
inflammatory responses
/
oxidative stress
刘明睿, 董佳豪, 袁铖, 吴昊, 钱冰露, 高子涵, 刘应蛟.
黄酮类化合物在胆汁淤积性肝损伤治疗中的作用及机制研究进展.
中草药,
2025
, 56
(16)
: 5981
-5993
.
DOI: 10.7501/j.issn.0253-2670.2025.16.026
LIU Mingrui, DONG Jiahao, YUAN Cheng, WU Hao, QIAN Binglu, GAO Zihan, LIU Yingjiao.
Research progress on effects and mechanisms of flavonoids in treatment of cholestatic liver injury[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(16)
: 5981
-5993
.
DOI: 10.7501/j.issn.0253-2670.2025.16.026
Year 2025 volume 56 Issue 16
43
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.16.026
- Receive Date:2025-03-01
- Online Date:2026-11-12